Genovis AB enters settlement and license agreement with Promega Corporation in patent infringement case
In November 2014, Genovis filed a complaint for patent infringement by Promega in the US regarding one of Promega’s products that concerns Genovis’s product FabRICATOR, originally developed using technology licensed from Hansa Medical. Genovis and Promega have now reached a settlement agreement, which includes a license agreement between the two parties.
The license agreement allows both parties to continue worldwide sale of IdeS and IdeZ products such as FabRICATOR for non-clinical applications such as the analysis of antibodies and the production of IgG-fragments.
Neither of the two agreements have any financial or commercial implications on Hansa Medical’s ongoing business.
For further information, please contact:
Hansa Medical AB
Göran Arvidson, CEO
Mobile: 46 70-633 30 42